BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2780643)

  • 1. Indapamide binding to alpha 1-acid glycoprotein: consequences on its blood distribution and plasma binding in disease states.
    Urien S; Guez D; Thénot A; Tillement JP
    Prog Clin Biol Res; 1989; 300():449-52. PubMed ID: 2780643
    [No Abstract]   [Full Text] [Related]  

  • 2. Binding of indapamide to serum proteins and erythrocytes.
    Urien S; Riant P; Renouard A; Coulomb B; Rocher I; Tillement JP
    Biochem Pharmacol; 1988 Aug; 37(15):2963-6. PubMed ID: 3395370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of competitive red blood cell binding and reduced hematocrit on the blood and plasma levels of [14C]Indapamide in the rat.
    Lettieri JT; Portelli ST
    J Pharmacol Exp Ther; 1983 Feb; 224(2):269-72. PubMed ID: 6822954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum binding of indapamide in health and disease: primary role of alpha 1-acid glycoprotein.
    Urien S; Morin D; d'Athis P; Coulomb B; Tillement JP
    J Clin Pharmacol; 1988 May; 28(5):458-62. PubMed ID: 3392244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of 5-methoxypsoralen to blood fractions. Influence of albumin and free fatty acids: an in vitro study.
    Muret P; Makki S; Urien S; Agache P; Bechtel P; Tillement JP
    Skin Pharmacol; 1993; 6(1):45-51. PubMed ID: 7683892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of bornaprolol to human serum proteins and blood cells.
    Shastri RA; Barre J; Houin G; Hamberger C; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1986 Jul; 24(7):351-6. PubMed ID: 3733286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of minaprine to human serum proteins and erythrocytes.
    Barré J; Houin G; Jeanniot JP; Coirre C; Tillement JP
    Int J Clin Pharmacol Res; 1986; 6(1):1-9. PubMed ID: 3957500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of indapamide in plasma by HPLC].
    Gaetani E; Laureri CF; Vitto M; Borghi L; Elia GF; Novarini A
    Boll Chim Farm; 1986 Jan; 125(1):35-7. PubMed ID: 3730177
    [No Abstract]   [Full Text] [Related]  

  • 9. Elevated alpha-1-acid glycoprotein reduces the volume of distribution and systemic clearance of saquinavir.
    Holladay JW; Dewey MJ; Michniak BB; Wiltshire H; Halberg DL; Weigl P; Liang Z; Halifax K; Lindup WE; Back DJ
    Drug Metab Dispos; 2001 Mar; 29(3):299-303. PubMed ID: 11181499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma binding of an alpha-blocking agent, nicergoline--affinity for serum albumin and native and modified alpha 1-acid glycoprotein.
    Robert L; Migne J; Santonja R; Zini R; Schmid K; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1983 Jun; 21(6):271-6. PubMed ID: 6885199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding to alpha 1-acid glycoprotein and relevant apparent volume of distribution.
    Bree F; Houin G; Barre J; Riant P; Tillement JP
    Prog Clin Biol Res; 1989; 300():321-36. PubMed ID: 2674968
    [No Abstract]   [Full Text] [Related]  

  • 12. Semiautomated assay for indapamide in biological fluids.
    Grebow PE; Treitman JA; Yeung AK; Johnston MM
    J Pharm Sci; 1981 Mar; 70(3):306-8. PubMed ID: 7264897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of chlorpheniramine enantiomers to human plasma proteins.
    Hiep BT; Gimenez F; Khanh VU; Hung NK; Thuillier A; Farinotti R; Fernandez C
    Chirality; 1999; 11(5-6):501-4. PubMed ID: 10368923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of taxol to human plasma, albumin and alpha 1-acid glycoprotein.
    Kumar GN; Walle UK; Bhalla KN; Walle T
    Res Commun Chem Pathol Pharmacol; 1993 Jun; 80(3):337-44. PubMed ID: 8102493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships between binding of benzodiazepines to alpha-1-acid glycoprotein and human serum albumin and their retention on the protein and octadecylsilane columns.
    Sadlej-Sosnowska N
    Biomed Chromatogr; 1995; 9(3):150-1. PubMed ID: 7655304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple binding of bepridil in human blood.
    Albengres E; Urien S; Pognat JF; Tillement JP
    Pharmacology; 1984; 28(3):139-49. PubMed ID: 6201931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-performance liquid chromatographic analysis of indapamide (RHC 2555) in urine, plasma and blood.
    Choi RL; Rosenberg M; Grebow PE; Huntley TE
    J Chromatogr; 1982 Jun; 230(1):181-7. PubMed ID: 7107760
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of the binding of isradipine and darodipine to different plasma proteins on their transfer through the rat blood-brain barrier. Drug binding to lipoproteins does not limit the transfer of drug.
    Urien S; Pinquier JL; Paquette B; Chaumet-Riffaud P; Kiechel JR; Tillement JP
    J Pharmacol Exp Ther; 1987 Jul; 242(1):349-53. PubMed ID: 2956411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of a new multidrug resistance modulator, S9788, to human plasma proteins and erythrocytes.
    Urien S; Nguyen P; Bastian G; Lucas C; Tillement JP
    Invest New Drugs; 1995; 13(1):37-41. PubMed ID: 7499106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SKF 525A displaces drugs from serum alpha 1-acid glycoprotein binding sites.
    Belpaire FM; Chindavijak B; Bogaert MG
    J Pharmacol Exp Ther; 1987 Feb; 240(2):628-30. PubMed ID: 3806415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.